Larimar Therapeutics, Inc.LRMRNASDAQ
Loading
Year-over-year free cash flow growth rate
Percentile
P23
Within normal range
vs 5Y Ago
-2.8x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | -33.89% |
| Q3 2025 | -48.33% |
| Q2 2025 | 27.04% |
| Q1 2025 | -20.89% |
| Q4 2024 | 10.62% |
| Q3 2024 | -72.54% |
| Q2 2024 | -36.99% |
| Q1 2024 | -9.51% |
| Q4 2023 | -3.34% |
| Q3 2023 | -24.92% |
| Q2 2023 | 2.46% |
| Q1 2023 | -13.17% |
| Q4 2022 | -13.51% |
| Q3 2022 | 22.52% |
| Q2 2022 | -0.70% |
| Q1 2022 | 4.97% |
| Q4 2021 | 36.54% |
| Q3 2021 | -15.53% |
| Q2 2021 | 3.51% |
| Q1 2021 | -13.67% |
| Q4 2020 | 12.19% |
| Q3 2020 | 7.97% |
| Q2 2020 | -35.86% |
| Q1 2020 | -12.79% |
| Q4 2019 | -36.72% |
| Q3 2019 | -83.81% |
| Q2 2019 | 45.66% |
| Q1 2019 | 84.79% |
| Q4 2018 | -191.43% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | -213.49% |
| Q4 2017 | 0.00% |
| Q3 2017 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | -164.36% |
| Q4 2016 | 0.00% |
| Q3 2016 | 0.00% |
| Q2 2016 | 0.00% |
| Q1 2016 | 62.96% |